17 November 2022
AnaCardio Receives Regulatory Approval to Start a Phase 1b/2a Clinical Study in Heart Failure with AC01 in the EU and UK
8 September 2022
AnaCardio raises SEK 150 million to advance drug candidate AC01 in heart failure
Thank you for your form submission, we will get in contact with you shortly.